Product image of Mestinon (Pyridostigmine Bromide) supplied by GNH India

Mestinon

Active Ingredient:
Pyridostigmine Bromide
Origin:
EU

Mestinon (Pyridostigmine Bromide)

Pyridostigmine bromide, the active ingredient in Mestinon, is an acetylcholinesterase inhibitor presented as a tablet for oral use. It is employed to improve muscle strength in patients with myasthenia gravis, a chronic autoimmune disorder that causes fluctuating skeletal‑muscle weakness. It works by increasing the availability of acetylcholine at the neuromuscular junction, thereby enhancing transmission of nerve impulses to skeletal muscles.

GNH India supplies Mestinon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for regulated markets.

Manufacturer / TM Owner

Viatris Healthcare Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Mestinon (pyridostigmine bromide) is used in the management of neuromuscular transmission disorders, primarily myasthenia gravis.

  • Generalized myasthenia gravis: enhances overall muscle strength and reduces daily fatigue.
  • Ocular myasthenia gravis: improves eye muscle control, reducing ptosis and diplopia.
  • Myasthenic crisis (post‑operative or severe exacerbation): provides symptomatic relief while definitive therapies take effect.

How It Works

  • Pyridostigmine bromide is a reversible inhibitor of acetylcholinesterase. By binding to the active site of the enzyme at neuromuscular junctions, it prevents breakdown of acetylcholine, increasing its concentration in the synaptic cleft. The elevated acetylcholine enhances stimulation of nicotinic receptors on skeletal muscle fibers, improving neuromuscular transmission and muscle contraction. The effect is dose‑dependent and reversible, allowing normal cholinergic function to resume as the drug is cleared.

Side Effects

Pyridostigmine bromide may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects

  • Nausea: upset stomach often occurring after the first doses.
  • Diarrhea: loose stools that may be mild to moderate.
  • Abdominal cramps: discomfort in the stomach region.
  • Increased salivation: excess saliva production.
  • Sweating: heightened perspiration.
  • Muscle cramps: involuntary tightening of muscles.

Serious or Rare Side Effects

  • Bradycardia: abnormally slow heart rate that may require monitoring.
  • Severe bronchospasm: sudden narrowing of airways, especially in asthmatic patients.
  • Allergic reactions: rash, itching, angioedema, or anaphylaxis.
  • Paradoxical muscle weakness: worsening of weakness despite therapy.
  • Seizures: rare neurologic events requiring immediate medical attention.

Precautions & Warnings

When prescribing pyridostigmine bromide, clinicians should consider several safety precautions to minimize risk.

  • Renal impairment: adjust dose because the drug is excreted unchanged in urine.
  • Asthma or COPD: monitor for bronchospasm due to cholinergic effects.
  • Cardiac disease: observe for bradyarrhythmias or conduction abnormalities.
  • Concomitant anticholinergic drugs: may reduce therapeutic effect.
  • Pregnancy and lactation: use only if benefit outweighs potential risk (category unknown).
  • Store at ambient temperature: keep below 25°C in original packaging, protect from moisture.

Avoid Interactions

Pyridostigmine bromide can interact with other medications, altering its efficacy or safety profile.

Major Interactions (Avoid)

  • Beta‑blockers: may exacerbate bradycardia.
  • Succinylcholine: prolonged neuromuscular blockade.
  • Aminoglycoside antibiotics (e.g., gentamicin): may worsen neuromuscular weakness.

Moderate Interactions (Monitor Closely)

  • Anticholinergic agents (e.g., atropine): reduce drug effect.
  • Diuretics (e.g., furosemide): increase risk of hypokalemia, enhancing muscle cramps.
  • Muscle relaxants (e.g., dantrolene): may diminish therapeutic response.

Frequently Asked Questions

Mestinon contains pyridostigmine bromide, an acetylcholinesterase inhibitor indicated for the treatment of myasthenia gravis. It helps improve skeletal‑muscle strength and reduces fatigue in patients with this autoimmune neuromuscular disorder.

Pyridostigmine reversibly inhibits acetylcholinesterase, the enzyme that breaks down acetylcholine at the neuromuscular junction. By slowing this breakdown, more acetylcholine remains available to stimulate nicotinic receptors, enhancing nerve‑to‑muscle signaling and improving muscle contraction.

The appropriate dose of Mestinon is individualized by the prescribing clinician based on the patient’s severity of myasthenia gravis, renal function, age, and response to therapy. No fixed regimen is provided here; the prescriber sets the dosage and titration schedule.

The pregnancy category for pyridostigmine bromide is listed as unknown. It should be used during pregnancy or lactation only when the potential benefit justifies any possible risk to the fetus or infant, and under close medical supervision.

To request Mestinon, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

The primary alternative to pyridostigmine is neostigmine, another reversible acetylcholinesterase inhibitor. Pyridostigmine has a longer duration of action and is generally preferred for chronic outpatient management of myasthenia gravis, whereas neostigmine is often used for short‑term or intra‑operative situations.

Mestinon tablets should be stored at ambient temperature, preferably below 25 °C, in the original container to protect them from moisture and light. Keep the product out of reach of children and do not use after the expiry date printed on the label.

Mestinon is taken orally as a tablet, usually with a glass of water. It may be taken with or without food, but consistent timing relative to meals helps maintain stable blood levels. Patients should follow the prescriber’s instructions regarding frequency and any dose adjustments.

Serious adverse events include bradycardia (slow heart rate), severe bronchospasm especially in patients with asthma or COPD, and allergic reactions such as rash, angioedema, or anaphylaxis. Any sudden worsening of muscle weakness or respiratory difficulty should prompt immediate medical evaluation.

Mestinon is contraindicated in individuals with known hypersensitivity to pyridostigmine or any component of the tablet, in patients with mechanical intestinal or urinary obstruction, and in those with severe asthma or uncontrolled bronchospasm where cholinergic stimulation could be hazardous.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Pyridostigmine Bromide

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT